Amended Complaint Merges Medicis Investors' Claims

Law360, New York (May 19, 2009, 12:00 AM EDT) -- A legal battle launched against Medicis Pharmaceutical Corp. last year has expanded with the filing of a consolidated amended complaint, which merges proposed class action claims from a slew of investors that accuse the dermatological-drug maker and several of its executives of overstating profits for more than four years.

The latest version of the complaint, filed Monday in the U.S. District Court for the District of Arizona, alleges that the defendants issued materially false and misleading statements that eventually caused a one-day drop in the company's...
To view the full article, register now.